Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Recombinant PNKP Monoclonal Antibody

Product Specifications

Background

PNK (polynucleotide kinase) is a DNA repair enzyme that participates in single strand break repair and non-homologous end rejoining (NHEJ) for double strand breaks. PNK possesses a 5'-DNA kinase activity and a 3'-DNA phosphatase activity. It has three domains, a C terminal kinase domain, a central phosphatase domain, and an N-terminal forkhead associated (FHA) domain that is responsible for protein protein interactions. Reduction in expression of PNK by RNAi sensitizes cells to ionizing radiation and topoisomerase I inhibitors.

Abbreviation

PNKP

UniProt

Q96T60

Host

Rabbit

Reactivity

Human

Immunogen

Peptide. This information is proprietary to PTMab.

Target

AOA; EIEE; PNKP; AOA4; EIEE10; MCSZ; PNK

Clonality

Monoclonal,Recombinant

Clone

A752

Conjugation

Unconjugated

Applications

WB; IHC

Field of Research

Epigenetics and Nuclear Signaling

Purification

Protein A purified

Concentration

1 mg/mL

Dilution

WB 1:2000; IHC 1:100

Buffer

PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

Shipping Conditions

Ice bag

Storage Conditions

Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Calculated Molecular Weight

57 kDa

Observed Molecular Weight

60 kDa

Isotype

IgG, κ

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

PDCL (NM_005388) Human Recombinant Protein
TP303166 20 µg

PDCL (NM_005388) Human Recombinant Protein

Ask
View Details
TNFAIP8L2, NT (TNFAIP8L2, Tumor necrosis factor alpha-induced protein 8-like protein 2, Inflammation factor protein 20) (AP) discontinued
043066-AP 200 µL

TNFAIP8L2, NT (TNFAIP8L2, Tumor necrosis factor alpha-induced protein 8-like protein 2, Inflammation factor protein 20) (AP) discontinued

Ask
View Details
Vedolizumab (Biosimilar Reference Antibody) (ITGA4B7)
RA0426-01 100 µg

Vedolizumab (Biosimilar Reference Antibody) (ITGA4B7)

Ask
View Details
Vedolizumab (Biosimilar Reference Antibody) (ITGA4B7)
RA0426-02 1 mg

Vedolizumab (Biosimilar Reference Antibody) (ITGA4B7)

Ask
View Details
Vedolizumab (Biosimilar Reference Antibody) (ITGA4B7)
RA0426-03 5 mg

Vedolizumab (Biosimilar Reference Antibody) (ITGA4B7)

Ask
View Details
Vedolizumab (Biosimilar Reference Antibody) (ITGA4B7)
RA0426-04 10 mg

Vedolizumab (Biosimilar Reference Antibody) (ITGA4B7)

Ask
View Details